Mohamed Gamil

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim et al. · Journal of Clinical Oncology · 2024 · 94 citations · Full text

Risk Factors for Bleeding and Clinical Implications in Patients Undergoing Liver Transplantation

Mohamed Gamil, Jacques Pirenne, Hannah van Malenstein et al. · Transplantation Proceedings · 2012 · 52 citations

Clinical Implications, Hepatology, Solid Organ Transplantation +10

The first 24 hours after surgery

Mohamed Gamil, Anne Fanning · Anaesthesia · 1991 · 46 citations · Full text

Surgery, Post-operative Care, Hospital Medicine +16

Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis

Maissa El Raziky, Mohamed Gamil, Mohamed Ashour et al. · Journal of Viral Hepatitis · 2016 · 28 citations

Novel scores combining AFP with non‐invasive markers for prediction of liver fibrosis in chronic hepatitis C patients

Mohamed Gamil, Mohamed Alboraie, Mohammad El‐Sayed et al. · Journal of Medical Virology · 2018 · 26 citations